Gene · 7357
Papers2,116
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,116
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unlocking the mysteries of alpha-N-terminal methylation and its diverse regulatory functions. | J Biol Chem | 2023 | 37209820 | PubTator, text mining | PubMed |
| The C10orf76-PI4KB axis orchestrates CERT-mediated ceramide trafficking to the distal Golgi. | J Cell Biol | 2023 | 37195633 | PubTator, text mining | PubMed |
| Microbial characterization of the nasal cavity in patients with allergic rhinitis and non-allergic rhinitis. | Front Cell Infect Microbiol | 2023 | 37180436 | PubTator, text mining | PubMed |
The Two Substrate Reduction Therapies for Type 1 Gaucher Disease Are Not Equivalent. Comment on Hughes et al. Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS). J. Clin. Med. 2022, 11, 5158. | J Clin Med | 2023 | 37176709 | PubTator, text mining | PubMed |
| Revealing the roles of glycosphingolipid metabolism pathway in the development of keloid: a conjoint analysis of single-cell and machine learning. | Front Immunol | 2023 | 37168863 | PubTator, text mining | PubMed |
| Antiviral activity of glucosylceramide synthase inhibitors in alphavirus infection of the central nervous system. | Brain Commun | 2023 | 37168733 | PubTator, text mining | PubMed |
| Fabry Disease and Its Management: A Literature Analysis. | Cureus | 2023 | 37153259 | PubTator, text mining | PubMed |
| Clickable Shiga Toxin B Subunit for Drug Delivery in Cancer Therapy. | ACS Omega | 2023 | 37151527 | PubTator, text mining | PubMed |
| Lithium ameliorates Niemann-Pick C1 disease phenotypes by impeding STING/SREBP2 activation. | iScience | 2023 | 37128603 | PubTator, text mining | PubMed |
| Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome. | Int J Mol Sci | 2023 | 37108615 | PubTator, text mining | PubMed |
| Reduced sulfatide content in deferoxamine-induced senescent HepG2 cells. | Int J Biochem Cell Biol | 2023 | 37086817 | PubTator, text mining | PubMed |
| Targeting inhibition of prognosis-related lipid metabolism genes including CYP19A1 enhances immunotherapeutic response in colon cancer. | J Exp Clin Cancer Res | 2023 | 37055842 | PubTator, text mining | PubMed |
| Sphingosine Kinases Promote Ebola Virus Infection and Can Be Targeted to Inhibit Filoviruses, Coronaviruses, and Arenaviruses Using Late Endocytic Trafficking to Enter Cells. | ACS Infect Dis | 2023 | 37053583 | PubTator, text mining | PubMed |
| Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19. | Int J Mol Sci | 2023 | 37047594 | PubTator, text mining | PubMed |
| Therapeutic Mechanism of Baicalin in Experimental Colitis Analyzed Using Network Pharmacology and Metabolomics. | Drug Des Devel Ther | 2023 | 37025160 | PubTator, text mining | PubMed |
| Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia. | Front Oncol | 2023 | 37020867 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| Ligand Activation of the Aryl Hydrocarbon Receptor Upregulates Epidermal Uridine Diphosphate Glucose Ceramide Glucosyltransferase and Glucosylceramides. | J Invest Dermatol | 2023 | 37004877 | PubTator, text mining | PubMed |
| Convenient and Sensitive Measurement of Lactosylceramide Synthase Activity Using Deuterated Glucosylceramide and Mass Spectrometry. | Int J Mol Sci | 2023 | 36982367 | PubTator, text mining | PubMed |
| Anoxia Rapidly Induces Changes in Expression of a Large and Diverse Set of Genes in Endothelial Cells. | Int J Mol Sci | 2023 | 36982232 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7357/papers?page=11